Core Insights - The announcement by the Hubei Provincial Drug Administration indicates that two companies, Jianmin Group Yekaitai Pharmaceutical (Suizhou) Co., Ltd. and Hubei Tianji Pharmaceutical Co., Ltd., have passed the GAP (Good Agricultural Practices) extension inspection for traditional Chinese medicine materials [3][4] Group 1: Company Information - Jianmin Group Yekaitai Pharmaceutical (Suizhou) Co., Ltd. is involved in the production of traditional Chinese medicine materials, specifically for the herb "Lianqiao" (Forsythia) with a cultivation area of 3,200 mu [3] - Hubei Tianji Pharmaceutical Co., Ltd. specializes in traditional Chinese medicine pieces, particularly "Chaihu" (Bupleurum) with a cultivation area of 3,500 mu [4] Group 2: Inspection Results - Both companies have been evaluated and found to meet the required standards for GAP, which is essential for ensuring the quality of traditional Chinese medicine production [3][4] - The inspection results include specific geographic coordinates for the cultivation bases, indicating precise locations for compliance verification [3][4]

Group 1 - The Hebei Provincial Drug Administration conducted GAP (Good Agricultural Practices) extension inspections on several traditional Chinese medicine (TCM) cultivation bases, confirming compliance with quality management standards [2] - The inspected companies include Shenwei Pharmaceutical Group, Anguo Shengshan Pharmaceutical Co., and Shijiazhuang Yiling Pharmaceutical Co., with all results meeting the required standards [2] - The inspection results are part of the implementation of the national quality management guidelines for TCM production, aimed at ensuring the quality and safety of herbal medicines [2] Group 2 - Shenwei Pharmaceutical Group's cultivation bases for Chuanxiong and related products were evaluated, with a total area of 650 acres across two locations in Sichuan Province [2] - Shijiazhuang Yiling Pharmaceutical Co. has a gold flower cultivation base covering 1,100 acres in Hebei Province, which also passed the inspection [2] - Anguo Shengshan Pharmaceutical Co. operates a half summer cultivation base of 1,185 acres, with multiple plots also meeting the compliance requirements [2]